Hybus Selects Netradyne to Ramp-up Safety in Luxury Bus Transportation with AI-Powered Driver*i Technology
Dec 20, 2024
Dec 20, 2024
Mumbai (Maharashtra) [India], December 20: Servier India has introduced its oncology portfolio with the launch of Onivyde® (nanoliposomal irinotecan) for metastatic pancreatic cancer. This launch aligns with Servier's commitment to providing therapies for hard-to-treat cancers, with an emphasis on improving patient outcomes and quality of life.
Dec 20, 2024